Urinary System Drugs Market Report

Global and Region Urinary System Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：201
  • REPORT CODE：GMM904150
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Urinary System Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Urinary System Drugsmarket, defines the market attractiveness level of Urinary System Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Urinary System Drugs industry, describes the types of Urinary System Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Urinary System Drugs market and the development prospects and opportunities of Urinary System Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Urinary System Drugs market in Chapter 13.

    By Player:

    • Astellas Pharma

    • Roche

    • Pfizer

    • Kunming Jida Pharmaceutical

    • Hunan Qianjin Xiang River Pharmaceutical

    • Eli Lilly

    • Cipla

    • Melinta Therapeutics

    • Daiichi Sankyo

    • Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

    • Novartis

    • Lupin

    • GSK

    • Cubist Pharmaceuticals

    • Mylan

    • Kowa

    • Dr Dunner

    • AstraZeneca

    • Bayer

    • Sanofi

    • Merck

    • Jiangsu Hengrui Pharmaceutical

    • Dr Reddy?s Laboratories

    • Jiangsu Lianhuan Pharmaceutical

    • Boehringer Ingelheim

    • Abbott Laboratories

    • Sun Pharma

    • Apogepha

    • Tianjin Tongrentang Group

    • Johnson & Johnson

    By Type:

    • Injection

    • Tablets

    • Capsule

    • Suppository

    • Granules

    • Powder

    • Pills

    • Cream

    • Others

    By End-User:

    • Kidney Disease Medication

    • Medication For Prostate Disease

    • Male Dysfunction

    • Lithotripsy Drug

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Urinary System Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Urinary System Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Urinary System Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Urinary System Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Urinary System Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Urinary System Drugs Consumption (2017-2022)

    • 7.2 United States Urinary System Drugs Consumption (2017-2022)

    • 7.3 Europe Urinary System Drugs Consumption (2017-2022)

    • 7.4 China Urinary System Drugs Consumption (2017-2022)

    • 7.5 Japan Urinary System Drugs Consumption (2017-2022)

    • 7.6 India Urinary System Drugs Consumption (2017-2022)

    • 7.7 South Korea Urinary System Drugs Consumption (2017-2022)

    8 Region and Country-wise Urinary System Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Urinary System Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Urinary System Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Urinary System Drugs Consumption Forecast (2022-2028)

    • 8.4 China Urinary System Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Urinary System Drugs Consumption Forecast (2022-2028)

    • 8.6 India Urinary System Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Urinary System Drugs Consumption Forecast (2022-2028)

    9 Global Urinary System Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Urinary System Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Injection Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Capsule Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Suppository Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Granules Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Powder Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Pills Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Cream Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Urinary System Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Kidney Disease Medication Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medication For Prostate Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Male Dysfunction Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Lithotripsy Drug Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Urinary System Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Urinary System Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Capsule Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Suppository Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Granules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Powder Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Pills Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Cream Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Urinary System Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Kidney Disease Medication Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Medication For Prostate Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Male Dysfunction Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Lithotripsy Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Urinary System Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Urinary System Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Urinary System Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Urinary System Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Urinary System Drugs Market Competitive Analysis

    • 14.1 Astellas Pharma

      • 14.1.1 Astellas Pharma Company Details

      • 14.1.2 Astellas Pharma Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astellas Pharma Urinary System Drugs Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Urinary System Drugs Product and Service

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Details

      • 14.3.2 Pfizer Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer Urinary System Drugs Product and Service

    • 14.4 Kunming Jida Pharmaceutical

      • 14.4.1 Kunming Jida Pharmaceutical Company Details

      • 14.4.2 Kunming Jida Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Kunming Jida Pharmaceutical Urinary System Drugs Product and Service

    • 14.5 Hunan Qianjin Xiang River Pharmaceutical

      • 14.5.1 Hunan Qianjin Xiang River Pharmaceutical Company Details

      • 14.5.2 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Product and Service

    • 14.6 Eli Lilly

      • 14.6.1 Eli Lilly Company Details

      • 14.6.2 Eli Lilly Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eli Lilly Urinary System Drugs Product and Service

    • 14.7 Cipla

      • 14.7.1 Cipla Company Details

      • 14.7.2 Cipla Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cipla Urinary System Drugs Product and Service

    • 14.8 Melinta Therapeutics

      • 14.8.1 Melinta Therapeutics Company Details

      • 14.8.2 Melinta Therapeutics Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Melinta Therapeutics Urinary System Drugs Product and Service

    • 14.9 Daiichi Sankyo

      • 14.9.1 Daiichi Sankyo Company Details

      • 14.9.2 Daiichi Sankyo Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Daiichi Sankyo Urinary System Drugs Product and Service

    • 14.10 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

      • 14.10.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Details

      • 14.10.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Product and Service

    • 14.11 Novartis

      • 14.11.1 Novartis Company Details

      • 14.11.2 Novartis Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis Urinary System Drugs Product and Service

    • 14.12 Lupin

      • 14.12.1 Lupin Company Details

      • 14.12.2 Lupin Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Lupin Urinary System Drugs Product and Service

    • 14.13 GSK

      • 14.13.1 GSK Company Details

      • 14.13.2 GSK Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 GSK Urinary System Drugs Product and Service

    • 14.14 Cubist Pharmaceuticals

      • 14.14.1 Cubist Pharmaceuticals Company Details

      • 14.14.2 Cubist Pharmaceuticals Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Cubist Pharmaceuticals Urinary System Drugs Product and Service

    • 14.15 Mylan

      • 14.15.1 Mylan Company Details

      • 14.15.2 Mylan Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Mylan Urinary System Drugs Product and Service

    • 14.16 Kowa

      • 14.16.1 Kowa Company Details

      • 14.16.2 Kowa Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Kowa Urinary System Drugs Product and Service

    • 14.17 Dr Dunner

      • 14.17.1 Dr Dunner Company Details

      • 14.17.2 Dr Dunner Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Dr Dunner Urinary System Drugs Product and Service

    • 14.18 AstraZeneca

      • 14.18.1 AstraZeneca Company Details

      • 14.18.2 AstraZeneca Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 AstraZeneca Urinary System Drugs Product and Service

    • 14.19 Bayer

      • 14.19.1 Bayer Company Details

      • 14.19.2 Bayer Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Bayer Urinary System Drugs Product and Service

    • 14.20 Sanofi

      • 14.20.1 Sanofi Company Details

      • 14.20.2 Sanofi Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Sanofi Urinary System Drugs Product and Service

    • 14.21 Merck

      • 14.21.1 Merck Company Details

      • 14.21.2 Merck Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Merck Urinary System Drugs Product and Service

    • 14.22 Jiangsu Hengrui Pharmaceutical

      • 14.22.1 Jiangsu Hengrui Pharmaceutical Company Details

      • 14.22.2 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Product and Service

    • 14.23 Dr Reddy?s Laboratories

      • 14.23.1 Dr Reddy?s Laboratories Company Details

      • 14.23.2 Dr Reddy?s Laboratories Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Dr Reddy?s Laboratories Urinary System Drugs Product and Service

    • 14.24 Jiangsu Lianhuan Pharmaceutical

      • 14.24.1 Jiangsu Lianhuan Pharmaceutical Company Details

      • 14.24.2 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Product and Service

    • 14.25 Boehringer Ingelheim

      • 14.25.1 Boehringer Ingelheim Company Details

      • 14.25.2 Boehringer Ingelheim Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Boehringer Ingelheim Urinary System Drugs Product and Service

    • 14.26 Abbott Laboratories

      • 14.26.1 Abbott Laboratories Company Details

      • 14.26.2 Abbott Laboratories Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Abbott Laboratories Urinary System Drugs Product and Service

    • 14.27 Sun Pharma

      • 14.27.1 Sun Pharma Company Details

      • 14.27.2 Sun Pharma Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Sun Pharma Urinary System Drugs Product and Service

    • 14.28 Apogepha

      • 14.28.1 Apogepha Company Details

      • 14.28.2 Apogepha Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 Apogepha Urinary System Drugs Product and Service

    • 14.29 Tianjin Tongrentang Group

      • 14.29.1 Tianjin Tongrentang Group Company Details

      • 14.29.2 Tianjin Tongrentang Group Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.29.3 Tianjin Tongrentang Group Urinary System Drugs Product and Service

    • 14.30 Johnson & Johnson

      • 14.30.1 Johnson & Johnson Company Details

      • 14.30.2 Johnson & Johnson Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.30.3 Johnson & Johnson Urinary System Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Urinary System Drugs

    • Figure Urinary System Drugs Picture

    • Table Global Urinary System Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Urinary System Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Urinary System Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Urinary System Drugs Consumption by Country (2017-2022)

    • Figure United States Urinary System Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Urinary System Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Urinary System Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Urinary System Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Urinary System Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Urinary System Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Urinary System Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Urinary System Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Urinary System Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Urinary System Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Urinary System Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Urinary System Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Urinary System Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Capsule Consumption and Growth Rate (2017-2022)

    • Figure Global Suppository Consumption and Growth Rate (2017-2022)

    • Figure Global Granules Consumption and Growth Rate (2017-2022)

    • Figure Global Powder Consumption and Growth Rate (2017-2022)

    • Figure Global Pills Consumption and Growth Rate (2017-2022)

    • Figure Global Cream Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Disease Medication Consumption and Growth Rate (2017-2022)

    • Figure Global Medication For Prostate Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Male Dysfunction Consumption and Growth Rate (2017-2022)

    • Figure Global Lithotripsy Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Suppository Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Granules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Powder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pills Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cream Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Disease Medication Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medication For Prostate Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Male Dysfunction Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lithotripsy Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Urinary System Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Urinary System Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Urinary System Drugs Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Urinary System Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Urinary System Drugs Product and Service

    • Table Kunming Jida Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kunming Jida Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kunming Jida Pharmaceutical Urinary System Drugs Product and Service

    • Table Hunan Qianjin Xiang River Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Urinary System Drugs Product and Service

    • Table Cipla (Foundation Year, Company Profile and etc.)

    • Table Cipla Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Urinary System Drugs Product and Service

    • Table Melinta Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Melinta Therapeutics Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Melinta Therapeutics Urinary System Drugs Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Urinary System Drugs Product and Service

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Urinary System Drugs Product and Service

    • Table Lupin (Foundation Year, Company Profile and etc.)

    • Table Lupin Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lupin Urinary System Drugs Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Urinary System Drugs Product and Service

    • Table Cubist Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Cubist Pharmaceuticals Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cubist Pharmaceuticals Urinary System Drugs Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Urinary System Drugs Product and Service

    • Table Kowa (Foundation Year, Company Profile and etc.)

    • Table Kowa Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kowa Urinary System Drugs Product and Service

    • Table Dr Dunner (Foundation Year, Company Profile and etc.)

    • Table Dr Dunner Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Dunner Urinary System Drugs Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Urinary System Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Urinary System Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Urinary System Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Urinary System Drugs Product and Service

    • Table Jiangsu Hengrui Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Hengrui Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Hengrui Pharmaceutical Urinary System Drugs Product and Service

    • Table Dr Reddy?s Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy?s Laboratories Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy?s Laboratories Urinary System Drugs Product and Service

    • Table Jiangsu Lianhuan Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Urinary System Drugs Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Urinary System Drugs Product and Service

    • Table Sun Pharma (Foundation Year, Company Profile and etc.)

    • Table Sun Pharma Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Urinary System Drugs Product and Service

    • Table Apogepha (Foundation Year, Company Profile and etc.)

    • Table Apogepha Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apogepha Urinary System Drugs Product and Service

    • Table Tianjin Tongrentang Group (Foundation Year, Company Profile and etc.)

    • Table Tianjin Tongrentang Group Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tianjin Tongrentang Group Urinary System Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Urinary System Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Urinary System Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US